News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Schindel Yair Chaim
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/13/2023 |
SC 13G
| Schindel Yair Chaim reports a 6% stake in Akoya Biosciences, Inc. |
| 05/18/2023 |
SC 13D/A
| Schindel Yair Chaim reports a 7.7% stake in SOPHiA GENETICS SA |
| 01/30/2023 |
3
| aMoon Growth Fund Limited Partnership (10% Owner) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
| 01/30/2023 |
SC 13G
| Schindel Yair Chaim reports a 12.2% stake in Ayala Pharmaceutics, Inc |
| 01/24/2023 |
4
| aMoon Growth Fund Limited Partnership (10% Owner) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 2,991,473 shares
@ $0 |
|
| 01/23/2023 |
SC 13G/A
| Schindel Yair Chaim reports a 0% stake in Ayala Pharmaceutics, Inc |
| 01/10/2023 |
SC 13D/A
| Schindel Yair Chaim reports a 19.4% stake in Viracta Therapeutics, Inc. |
| 01/10/2023 |
SC 13D/A
| Schindel Yair Chaim reports a 19.4% stake in Viracta Therapeutics, Inc. |
| 01/10/2023 |
SC 13D
| Schindel Yair Chaim reports a 5% stake in SOPHiA GENETICS SA |
| 01/09/2023 |
SC 13G/A
| Schindel Yair Chaim reports a 20.2% stake in Ayala Pharmaceutics, Inc |
| 01/09/2023 |
SC 13G/A
| Schindel Yair Chaim reports a 6.2% stake in Sera Prognostics, Inc. |
| 01/09/2023 |
SC 13G/A
| Schindel Yair Chaim reports a 7.9% stake in Seer, Inc. |
| 01/24/2022 |
SC 13G
| Schindel Yair Chaim reports a 6.2% stake in Sera Prognostics, Inc. |
| 01/24/2022 |
SC 13G/A
| Schindel Yair Chaim reports a 21.5% stake in Ayala Pharmaceutics, Inc. |
| 01/24/2022 |
SC 13G/A
| Schindel Yair Chaim reports a 8% stake in Seer, Inc. |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/01/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/18/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/10/2020 |
4
| aMoon 2 Fund Limited Partnership (10% Owner) has filed a Form 4 on Seer, Inc.|
Txns:
| Converted 4,121,064 shares
@ $0
Bought 100,000 shares
@ $19, valued at
$1.9M
Bought 726,449 shares
@ $19, valued at
$13.8M
Converted 912,659 shares
@ $0
Bought 63,024 shares
@ $19, valued at
$1.2M
Converted 2,875,628 convertible preferred
@ $0
Converted 1,245,436 convertible preferred
@ $0
Converted 787,380 convertible preferred
@ $0
Converted 125,279 convertible preferred
@ $0 |
|
| 12/03/2020 |
3
| aMoon 2 Fund Limited Partnership (10% Owner) has filed a Form 3 on Seer, Inc. |
| 12/03/2020 |
SC 13D/A
| Schindel Yair Chaim reports a 5.6% stake in Adicet Bio, Inc. |
| 09/24/2020 |
SC 13D
| Schindel Yair Chaim reports a 5.8% stake in Adicet Bio, Inc. |
| 09/17/2020 |
4
| Schindel Yair Chaim (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 1,104,460 shares
@ $0
Granted 30,000 options to buy
@ $16.11, valued at
$483.3k
|
|
| 09/17/2020 |
3
| Schindel Yair Chaim (Director) has filed a Form 3 on Adicet Bio, Inc. |
|
|